Trial NCT01032291

View at ClinicalTrials.gov 
Org. Study IDs: CC-5013-COLO-001
Secondary IDs: 2009-012665-61

Last trial update was posted on 2013-05-21

MeSH Interventions

Cetuximab Lenalidomide

MeSH Conditions

Colorectal Neoplasms

Other Conditions

Colorectal Cancer

Stopping Reasons

A business decision not to continue with Phase 2b based on non-safety observations during proof of concept phase.

Limitations And Caveats

Enrollment stopped prematurely due to lack of efficacy and failure to achieve the planned response objective.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID